MERUS LABS INTERNATIONAL INC T.MSL

Healthcare Drug Manufacturers - Specialty & Generic

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post by User

MERUS LABS INTERNATIONAL INC > Challenging markets

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Sep 18, 2015 8:48pm

94 Views

Post# 24117690

RE:RE:RE:Challenging markets

latest qtr eps go from (0.02) to 0.05 by backing out amort. That's $0.20 annualized which means p/e is only 10x

lscfa wrote: you bashing moron. eps is a piss poor metric because there is $6 million/qtr of amortization of intangible assets.

Craigbad wrote: I would suggest having a look at the latest Thomson Resuters report. Msl has been downgraded to a 2 out of 10 and is now ranked in the bottom 15% of stocks to own. Concensus earnings estimates have been downgraded significantly to only $0.049 cents per share next year. Even at a 30 x forward multiple a price of $1.50 would still be expensive but worth a shot. Some will argue "ebitda" multiple is cheap but you have to look at the balance sheet to understand why eps is important in msl case. Happy trading.